SCHEMBL17488332

SCHEMBL17488332

FC(F)(F)c1cc(Nc2ccc3nc(NCc4ccc(Oc5ccc(Cl)cn5)cc4)[nH]c3c2)n[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.40
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
TEK Q02763 1/20 0.38
CDK1 P06493 1/20 0.37
FABP4 P15090 1/20 0.36
P2RX3 P56373 1/20 0.36
RAF1 P04049 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
BRAF P15056 1/20 0.35
PDE10A Q9Y233 2/20 0.35
CSNK1A1 P48729 1/20 0.35
CSNK1D P48730 1/20 0.35
GSK3B P49841 1/20 0.35
CSNK1G2 P78368 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17488151 0.85 RAB9A (0.42) KDRRAB9ASMN1; SMN2TP53P2RX3
SCHEMBL17488256 0.82 CYP3A4 (0.39) TP53P2RX3CYP3A4LMNA
SCHEMBL17488014 0.81 POLB (0.50) KDRRAB9ASMN1; SMN2TP53TEK
SCHEMBL17488333 0.81 KDR (0.39) KDRRAB9ASMN1; SMN2TP53TEK
SCHEMBL17487718 0.79 RAB9A (0.43) KDRRAB9ASMN1; SMN2TP53TEK
SCHEMBL17487452 0.78 RAB9A (0.47) RAB9ASMN1; SMN2TP53CYP1A2CYP2D6
SCHEMBL17488143 0.78 RAB9A (0.40) KDRRAB9ASMN1; SMN2TP53CDK1
SCHEMBL17488029 0.78 RAB9A (0.43) KDRRAB9ASMN1; SMN2TP53RAF1
SCHEMBL17488016 0.77 TP53 (0.41) KDRRAB9ASMN1; SMN2TP53TEK
SCHEMBL17487750 0.77 P2RX3 (0.44) KDRRAB9ASMN1; SMN2TP53TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016016421-A1 2-AMINO-BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS 5-LIPOXYGENASE AND/OR PROSTAGLANDIN E SYNTHASE INHIBITORS INSTITUT PASTEUR KOREA (KR) 2016-02-04 WO disclosed